The laboratory’s activities are aimed at implementing scientific frontier research, creating an innovative ecosystem in the field of post-genomic, and omics technologies. The laboratory is focused on personalizing diagnostic technologies and treatment regimens for socially significant diseases, taking into account the patient's metabolic characteristics, including identifying key biomarkers that predict the characteristics of the disease, as well as developing systems for implementing targeted therapeutic effects to increase the duration and quality of life of the population.

Main areas:

  •  Establishment of advanced research infrastructure for the implementation of medical mass spectrometry technologies;
  •  Formation of new research groups focused on frontier scientific and technological projects in the field of biomedicine;
  •  Implementation of scientific and technological projects based on the created research infrastructure;
  •  Broadcasting the results of research projects within educational programs and schools for young scientists.

Equipment:

HPLC-MS/MS, including Waters Xevo TQ-S Micro LC-MS/MS with ACQUITY UPLC H-Class PLUS Core System HPLC.